Marion Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.51M Buy
3,761
+100
+3% +$102K 0.92% 27
2026
Q1
$3.37M Buy
3,661
+100
+3% +$101K 0.75% 34
2025
Q4
$3.79M Buy
3,561
+64
+2% +$61.2K 0.84% 30
2025
Q3
$2.67M Sell
3,497
-76
-2% -$56.6K 0.63% 42
2025
Q2
$2.79M Buy
3,573
+405
+13% +$315K 0.7% 36
2025
Q1
$2.62M Buy
3,168
+2,633
+492% +$2.19M 0.7% 36
2024
Q4
$413K Sell
535
-45
-8% -$37.3K 0.11% 95
2024
Q3
$514K Sell
580
-444
-43% -$399K 0.14% 89
2024
Q2
$927K Buy
1,024
+4
+0.4% +$3.2K 0.27% 76
2024
Q1
$794K Buy
1,020
+102
+11% +$72.6K 0.24% 79
2023
Q4
$535K Buy
+918
New +$536K 0.17% 83

Other funds holding LLY

Marion Wealth Management's LLY Position: Q2 2026 in Review

Marion Wealth Management increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $102K and bringing the position to 3,761 shares worth $4.51M. The position accounts for 0.92% of the portfolio, ranked #27.

Marion Wealth Management first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Marion Wealth Management held 3,761 shares of Eli Lilly worth $4.51M as of Q2 2026.
  • Marion Wealth Management bought 100 Eli Lilly shares in Q2 2026, an estimated $102K.
  • Eli Lilly made up 0.92% of Marion Wealth Management's portfolio in Q2 2026, its #27 holding.
  • Marion Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Marion Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.